The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Suppression of pituitary-adrenal function is a well-known consequence of glucocorticoid therapy, manifested principally by decreased corticotropin secretion. To determine the degree of suppression of pituitary-adrenal function in patients treated with different doses of synthetic glucocorticoid medication for different periods, we measured the pituitary-adrenal response to the administration of exogenous human corticotropin-releasing hormone (CRH). METHODS: We studied 279 patients who were receiving daily therapy with 5 to 30 mg of prednisone or its equivalent to treat various chronic diseases, principally collagen vascular disorders, and 50 normal subjects. Therapy ranged in duration from 1 week to 15 years. Stimulation tests using 100 micrograms of CRH as a bolus injection were performed in the morning, 24 hours after the most recent dose of glucocorticoids. In 61 patients an insulin hypoglycemia test, thought by many to be the reference standard, was also performed to assess the reliability of the CRH results. RESULTS: After the administration of CRH, 43 patients had no increase in plasma concentrations of corticotropin and cortisol. The response was blunted in 133 patients and normal in 103. There was poor correlation between the plasma cortisol response after the administration of CRH and the dose or duration of therapy or the basal plasma cortisol concentration. Although plasma cortisol concentrations after stimulation with CRH were generally lower than those after insulin administration, there was a significant correlation between the plasma cortisol responses to the two stimuli (r = 0.82). CONCLUSIONS: Pituitary-adrenal function in patients treated with synthetic glucocorticoids cannot be reliably estimated from the dose of glucocorticoid, the duration of therapy, or the basal plasma cortisol concentration. In such patients, testing with CRH is nearly as useful as insulin hypoglycemia testing in the assessment of pituitary-adrenal function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been established that serum cortisol values below 3 μg/dL rule in the diagnosis of AI, while levels above 18 μg/dL practically rule out AI [29,30,31].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [31]
In the citing paper
“It has been established that serum cortisol values below 3 μg/dL rule in the diagnosis of AI, while levels above 18 μg/dL practically rule out AI [29,30,31].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [31]
In the citing paper
“however, some studies proved that even treatment with physiological doses of GCs might precipitate AI [11,31].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [31]
In the citing paper
“Due to their large therapeutic diffusion, synthetic GCs treatment represents one of the most frequent causes of secondary adrenal insufficiency [13].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [13]
In the citing paper
“It is not clear whether or not the dose and the duration of GCs therapy increase the risk of developing adrenal insufficiency: some authors found no relationship between either the dose or duration of therapy and adrenal insufficiency [13], while others found that both cumulative doses and treatment durations are associated with an increased risk of adrenal insufficiency [79].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [13]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Adrenal steroid receptors and actions in the nervous system
McEwen, B. S., De Kloet, E. R., & Rostene, W. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.1121 · Cited by 1,232
Corticosteroid inhibition of acth secretion
KELLER-WOOD, M. E., & DALLMAN, M. F. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-1 · Cited by 1,219
VALE, W., VAUGHAN, J., SMITH, M., & YAMAMOTO, G. (1983) · Endocrinology · doi:10.1210/endo-113-3-1121 · Cited by 563
A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
Stewart, P. M., Seckl, J. R., Corrie, J., Edwards, C. R. W., & Padfield, P. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92020-x · Cited by 418
AXELROD, L. (1976) · Medicine · doi:10.1097/00005792-197601000-00003 · Cited by 326
JINGAMI, H., MATSUKURA, S., NUMA, S., & IMURA, H. (1985) · Endocrinology · doi:10.1210/endo-117-4-1314 · Cited by 271
Orth, D. N., Jackson, R. V., DeCherney, G. S., DeBold, C. R., Alexander, A. N., Island, D. P., Rivier, J., Rivier, C., Spiess, J., & Vale, W. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110804 · Cited by 246
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233
MELBY, J. C. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-505 · Cited by 222
Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary.
Eberwine, J. H., & Roberts, J. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43332-1 · Cited by 221
SCHÜRMEYER, T. H., AVGERINOS, P. C., GOLD, P. W., GALLUCCI, W. T., TOMAI, T. P., CUTLER, G. B., LORIAUX, D. L., & CHROUSOS, G. P. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1103 · Cited by 206
Pituitary adrenal recovery following short-term suppression with corticosteroids
Streck, W. F., & Lockwood, D. H. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90444-3 · Cited by 178
RECOVERY OF HYPOTHALAMO-PITUITARY-ADRENAL FUNCTION AFTER CORTICOSTEROID THERAPY
Livanou, T., Ferriman, D., & James, V. H. T. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92592-5 · Cited by 176
Corticotropin-Releasing Hormone
Taylor, A. L., & Fishman, L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190405 · Cited by 176
Normal and Abnormal Function of the Hypothalamic Pituitary-Adrenocortical System in Man*
STREETEN, D. H. P., ANDERSON, G. H., DALAKOS, T. G., SEELEY, D., MALLOV, J. S., EUSEBIO, R., SUNDERLIN, F. S., BADAWY, S. Z. A., & KING, R. B. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-371 · Cited by 137
Normal Cortisol Response to Corticotropin in Patients With Secondary Adrenal Failure
Cunningham, S. K. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.12.2276 · Cited by 126
Borst, G. C., Michenfelder, H. J., & O'Brian, J. T. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062405 · Cited by 111
SCHÜRMEYER, T. H., TSOKOS, G. C., AVGERINOS, P. C., BALOW, J. E., D'AGATA, R., LORIAUX, D. L., & CHROUSOS, G. P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-1-22 · Cited by 54
Kelly, A., Nelson, K., Goodwin, M., & McCluggage, J. (1972) · BMJ · doi:10.1136/bmj.4.5832.114-a · Cited by 42
HARRISON, B. D. W., REES, L. H., CAYTON, R. M., & NABARRO, J. D. N. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb01570.x · Cited by 41
2 Disorders of the hypothalamic-pituitary-adrenal axis
Wand, G. S., & Ney, R. L. (1985) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(85)80064-5 · Cited by 36
Effects of Dexamethasone on Central and Peripheral ACTH Systems in the Rat
Carnes, M., Barksdale, C. M., Kalin, N. H., Brownfield, M. S., & Lent, S. J. (1987) · Neuroendocrinology · doi:10.1159/000124718 · Cited by 36
Müller, O. A., Hartwimmer, J., Hauer, A., Kaliebe, T., Schopohl, J., Stalla, G. K., & von Werder, K. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90031-4 · Cited by 24
Safety and side effects of human and ovine corticotropin-releasing hormone administration in man
Nink, M., Krause, U., Lehnert, H., & Beyer, J. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01646939 · Cited by 17
RECOVERY FROM GLUCOCORTICOID INHIBITION OF THE RESPONSES TO CORTICOTROPHIN‐RELEASING HORMONE
WATSON, A. C., Rosenfield, R. L., & Fang, V. S. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03681.x · Cited by 15
Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
Hashimoto, K., Suemaru, S., Takao, T., Sugawara, M., Hattori, T., Kageyama, J., Takahashi, K., & Ota, Z. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113561 · Cited by 7
Research works printed but not linked: 3
- Bolt, 1980, Therapiewoche, 30, 6257
- Voigt, 1981, Therapiewoche, 31, 6230
- Becker KL. Endocrine drugs and values. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: J.B. Lippincott, 1990:1740.
Cited by
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Oral Budesonide for Active Crohn's Disease
Greenberg, G. R., Feagan, B. G., Martin, F., Sutherland, L. R., Thomson, A., Williams, C. N., Nilsson, L.-G., & Persson, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311303 · Cited by 563
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Metadata
- Authors
- Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-01-23
- Volume
- 326
- Issue
- 4
- Pages
- 226-230
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1976008242
- Cited by
- 381
- References
- 28
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 12 · 2023: 5 · 2022: 8 · 2021: 10 · 2020: 11 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 12 · 2014: 11 · 2013: 17 · 2012: 10
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- glucocorticoid therapy, pituitary-adrenal axis, corticotropin-releasing hormone stimulation test, prednisone, insulin hypoglycemia test, plasma cortisol, connective tissue diseases, long-term corticosteroid therapy
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Aged, Aged, 80 and over, Blood Glucose, Corticotropin-Releasing Hormone, Depression, Chemical, Female, Glucocorticoids, Humans, Hydrocortisone, Insulin, Male, Middle Aged, Pituitary-Adrenal Function Tests, Pituitary-Adrenal System, Prednisone, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.